Cloud-Based Software Reporting of PGx for Hospitals, Health Systems and Clinical Laboratories
Although the value of PGx testing is abundantly clear, it does present a number of challenges to physicians, clinical diagnostic laboratories, and healthcare institutions. A primary challenge is the difficulty of analyzing the complex amount of information involved in PGx testing and comparing it to the drugs the patient is being prescribed—and then turning that information into actionable intelligence that a busy physician can use to drive good medical care, in a cost-effective, efficient and reliable manner.
This FREE downloadable White Paper discusses practical ways in which healthcare providers can hurdle these, and other obstacles, and will provide you with a detailed discussion regarding the importance of PGx testing in today’s healthcare environment.
After reviewing it, you will possess a greater understanding of the obstacles physicians, laboratories and hospitals face when launching a pharmacogenomics program, how PGx testing can be used to drive patient care, and the important role cloud-based software can play in making PGx testing a practical and cost-effective solution.
This White Paper specifically addresses:
- The ways in which pharmacogenomics can lead to an ultimate overall decrease in healthcare costs
- Myriad benefits that pharmacogenomics testing can provide patients
- How numerous studies support the clinical usefulness of PGx testing
- Various barriers to entry into the pharmacogenomic testing market
- Outsourcing as a solution to making PGx testing a viable option for laboratories
- The many advantages to a service that specializes in PGx interpretation
- Today’s status of genomic testing in the lab market, and what the future may hold
Table of Contents
Introduction: An Overview of Pharmacogenomic Testing and Clinical Services
Chapter 1: PGx, Healthcare Reform, and Improving Patient Outcomes
Chapter 2: Obstacles to Overcome When Launching a PGx Program
Chapter 3: Using PGx to Enhance Clinical Utility and Patient Outcomes
Chapter 4: Understanding the Role of Cloud-Based Software for PGx Reporting
Conclusion: The Future
For an enlightening overview of pharmacogenomic testing and how PGx fits into current healthcare goals, a discussion of the obstacles healthcare providers, institutions and clinical diagnostic laboratories face in entering the pharmacogenomic testing market, and examples of how a cloud-based, Software-as-a-Service platform can help healthcare providers overcome those obstacles, download your FREE copy of “A Lab Leader’s Guide to Pharmacogenomic Testing (PGx): Cloud-Based Software Reporting of PGx for Hospitals, Health Systems and Clinical Laboratories.”
Download the White Paper now by completing the form below.